HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ST segment analysis by Holter Monitoring: methodological considerations.

AbstractBACKGROUND:
There has been a renewed interest in ST segment analysis by Holter Monitoring, especially in multicenter clinical trials, but consensus on how to define an ischemic event is missing. We conducted a survey of European and U.S. publications involving ST segment analysis by Holter monitoring from 1975 to 2002 and found no notation of any correction for baseline ST segment depression in 52% of them. In 45% J-point depression was required in addition to ST segment depression measured either 60 ms (24%) or 80 ms (76%) after the J point. In 28% ST segment elevations were included.
METHOD:
Four different criteria for an ischemic event found in our survey were applied to Holter recordings from 66 patients with acute ischemic syndrome enrolled in the Esmolol Myocardial Ischemia Trial (EMIT). Only lead CM5 was used and the analyzer was a Reynolds Medical Pathfinder 600.
RESULTS:
By the most sensitive method (J + 80), there were 16 (24%) patients who had ischemic events in their Holter recording compared to only 10 (15%) patients if J-point depression was also required. If corrections were made for baseline ST segment depression, only 3 (4.5%) recordings were positive for ischemia.
CONCLUSION:
The outcome of Holter analysis for ischemic events is greatly dependent upon how an ischemic event is defined. Consensus on how to define an ischemic event is urgently needed.
AuthorsPreben Bjerregaard, Amr El-Shafei, Susan L Kotar, Arthur J Labovitz
JournalAnnals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc (Ann Noninvasive Electrocardiol) Vol. 8 Issue 3 Pg. 200-7 (Jul 2003) ISSN: 1082-720X [Print] United States
PMID14510654 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Review)
Topics
  • Data Collection
  • Electrocardiography, Ambulatory (methods)
  • Europe (epidemiology)
  • Heart Conduction System (pathology)
  • Humans
  • Myocardial Ischemia (diagnosis, epidemiology)
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: